We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00098202
First Posted: December 6, 2004
Last Update Posted: December 17, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Global Network for Women's and Children's Health Research
Bill and Melinda Gates Foundation
John E. Fogarty International Center (FIC)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Dental and Craniofacial Research (NIDCR)
National Cancer Institute (NCI)
RTI International
University of Colorado, Denver
Center for Studies of Sensory Impairment, Aging and Metabolism
Foundation for Alimentation and Nutrition, Central America and Panama
USDA Beltsville Human Nutrition Research Center
Information provided by (Responsible Party):
NICHD Global Network for Women's and Children's Health
December 3, 2004
December 6, 2004
December 17, 2013
March 2003
Not Provided
  • Infant Maize/Zn Supplementation Trial:
  • Linear growth velocity
  • Zn Homeostasis Studies:
  • Measures of zinc homeostasis
  • TRIAL 1: Maize Consumption
  • Mean birth weight
  • TRIAL 2: Infant Supplementation
  • Linear growth velocity
Complete list of historical versions of study NCT00098202 on ClinicalTrials.gov Archive Site
  • Infant Maize/Zn Supplementation Trial:
  • Weight gain
  • Morbidity
  • Infant neurodevelopment
  • Maternal and infant biomarkers
  • TRIAL 1: Maternal obstetric outcomes
  • Maternal morbidity
  • Infant infectious disease morbidity
  • Infant growth and development
  • Metabolic/biomarker outcomes
  • TRIAL 2: Infectious disease morbidity
  • Neurodevelopment measures
  • Zinc and iron status
Not Provided
Not Provided
 
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala
Malnutrition is a serious health problem in the developing world. This study looks at the effects of changing the type of basic food staple (corn) used in Guatemala and infant zinc supplementation on infants' growth, development, and illnesses from infectious diseases.

Poor mineral nutrition, especially deficiencies of iron and zinc, is a major cause of maternal and, especially, infant morbidity/mortality in developing world countries. The objectives of this study are to determine whether: a) linear growth velocity between 6 and 12 months in infants receiving a 5mg Zn supplement will be greater than that for infants receiving placebo; b) linear growth velocity will be greater for infants receiving complementary foods containing low phytate maize than for the infants fed wild-type control maize. In addition, Zn metabolic studies will be performed. The objective of the metabolic studies are to measure key variables of Zn homeostasis in maternal participants during changes in the reproductive cycle and in infants during a time when they are most vulnerable to Zn deficiency.

The primary outcome measurement is linear growth velocity between 6 and 12 months. Secondary outcomes are weight gain, diarrheal incidence/prevalence and infant neurodevelopmental measures. Optional maternal and infant biochemical data will be collected from a convenience sample comprised of willing participants.

One additional component to this study is to collect information on the nutritional status of the women receiving low-phytate vs. control maize and the infants enrolled in this study.

The current protocol for infants in this study specifies measurements of exchangeable zinc pool (EZP) at 6 and 12 months of age; in order to lessen the burden of study participation we plan to conduct the metabolic studies in infants at only nine months of age. In addition to decreasing the number of infant studies, this change will enable families who are only participating in the metabolic studies (not simultaneously enrolled in the sibling cohort) to cease all study demands at the end of the nine month measurement (an overall decrease of three months in study participation).

The primary outcome measure for this study is the quantity of zinc absorbed (mg/day)from complementary foods and a Zn supplement at age 9 months. The rationale for measures of zinc absorption in infants is that the low phytate complementary feeding is expected to have a beneficial public health effect only if it results in enhanced mineral, especially zinc, absorption. Therefore, confirmation of increased zinc absorption can be regarded as the first logical stage of any efficacy study.

The sample size of 420 is required in order to observe a 6% increase in growth rates for Zn supplemented infants compared to placebo treated infants within each maize group with 80% power.

Interventional
Phase 3
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Prevention
  • Nutrition
  • Pregnancy
  • Drug: Low phytic acid maize
  • Drug: Zinc
Not Provided
Hambidge KM, Mazariegos M, Kindem M, Wright LL, Cristobal-Perez C, Juárez-García L, Westcott JE, Goco N, Krebs NF. Infant stunting is associated with short maternal stature. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):117-9. doi: 10.1097/MPG.0b013e3182331748.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
420
April 2007
Not Provided

Inclusion criteria:

  • Informed consent of mother
  • Mother between the ages of 18 and 40 years
  • Mother typically eats homemade tortillas
  • Mother typically eats a minimum of 15 homemade tortillas per day.
  • Mother resides in a community served by the Comalapa, Chimaltenango, Community Health Center in the Western Highlands of Guatemala

Exclusion criteria:

  • Other member of the dwelling unti already enrolled in the study.
  • Mother has more than eight living children.
Sexes Eligible for Study: Female
18 Years to 40 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Guatemala
 
 
NCT00098202
GN 06
U01HD040657 ( U.S. NIH Grant/Contract )
Yes
Not Provided
Not Provided
NICHD Global Network for Women's and Children's Health
NICHD Global Network for Women's and Children's Health
  • Global Network for Women's and Children's Health Research
  • Bill and Melinda Gates Foundation
  • John E. Fogarty International Center (FIC)
  • National Center for Complementary and Integrative Health (NCCIH)
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Cancer Institute (NCI)
  • RTI International
  • University of Colorado, Denver
  • Center for Studies of Sensory Impairment, Aging and Metabolism
  • Foundation for Alimentation and Nutrition, Central America and Panama
  • USDA Beltsville Human Nutrition Research Center
Principal Investigator: Michael Hambidge, MD University of Colorado, Denver
NICHD Global Network for Women's and Children's Health
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP